Novel Rx
4 hours 36 minutes ago
🔍 Safety of a JAKi Across 15,000 Patient-Years of Data
Now in the RheumNow poster hall: Safety outcomes with a JAKi from 11 Phase 3 trials in adult patients with RA, PsA, AS, and nr-axSpA. Sponsored by AbbVie US Medical Affairs.
https://t.co/yeif38wKIY https://t.co/earZnqZLSI
6 hours 23 minutes ago
Summary of treatments in psoriatic arthritis #PsA @RheumNow #ACR24 https://t.co/EybzRCPLtA
ACR 2024 starts tomorrow. Here are a few previews of abstracts to be presented, along with my recommendations of sessions you don’t want to miss.Previews:Abstract Number: 2527 Efficacy and…
Poster Hall